NSAIDs target stem cells that have accumulated mutations that could lead to cancer development and a biochemical pathway that leads to apoptosis.
Many changes occur in the gastrointestinal tract during the aging process that can directly impact gastric motility following surgery.
[Cancer Control] Castleman disease is a lesser seen lymphoproliferative disorder, which is characterized as either localized or multicentric, with differing treatments typically utilized for each type.
The Eastern Cooperative Oncology Group (ECOG) conducted a trial to investigate whether treatment deintensification was feasible in patients with HPV-associated cancer.
Fall Digital Issue
From Oncology Nurse Advisor
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Burkitt Lymphoma
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
- Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients
- For Gastric Cancer, Adjuvant Chemoradiation Improves Survival
- Artesunate May Be Effective for Colorectal Cancer
- Androgen Deprivation Therapy in Men with Prostate Cancer and Increased Risk of Cardiovascular Events
- Cancer-Linked Weight Loss Diagnostic Criteria Developed
- Diagnosis and Management of Castleman Disease
- Treatment Deintensification for HPV-Associated Oropharynx Cancer
- IL-2 Effective in Metastatic Renal Cell Carcinoma (RCC) Patients with Favorable Histologies